phenylacetate carboxymethyl benzylamide dextran

dextran derivative; has a potent inhibitory effect on epidermoid carcinoma growth associated with an intratumour microvascular network diminution and an aponecrosis increase; as this drug is nontoxic at efficient dose, it offers interesting perspectives for the therapy of malignant lesions; structure in first source
Also Known As:
NaPaC cpd
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results


1. Perret, G Y: 1 article (06/2003)
2. Kraemer, M: 1 article (06/2003)
3. Crépin, M: 1 article (06/2003)
4. Starzec, A: 1 article (06/2003)
5. Di Benedetto, M: 1 article (06/2003)
6. Vassy, R: 1 article (06/2003)

Related Diseases

1. Squamous Cell Carcinoma (Epidermoid Carcinoma)

Related Drugs and Biologics

1. Angiogenesis Inducing Agents (Angiogenesis Factor)
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3. Dextrans (Dextran)